TCM
Tang Capital Management Portfolio holdings
AUM
$1.98B
1-Year Est. Return
21.62%
1 Year Est. Return
+21.62%
AUM
$1.81B
AUM Growth
+$296M
(+20%)
Holding
208
Top Buys
| 1 | +$50.6M | |
| 2 | +$45.2M | |
| 3 | +$33.1M | |
| 4 |
Spyre Therapeutics
SYRE
|
+$33.1M |
| 5 |
SLRN
ACELYRIN
SLRN
|
+$24.3M |
Top Sells
| 1 | +$10.6M | |
| 2 | +$7.23M | |
| 3 | +$4.82M | |
| 4 |
ALMS
Alumis Inc
ALMS
|
+$4.72M |
| 5 |
Seer Inc
SEER
|
+$1.52M |
Sector Composition
| 1 | Healthcare | 94.79% |
| 2 | Technology | 1.25% |
| 3 | Communication Services | 1.23% |
| 4 | Consumer Discretionary | 0.99% |
| 5 | Financials | 0.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Sutro Biopharma
STRO
$94.9M
| $130K | 0.01% |
+200,000
|
|
||
|
AFMD
202
DELISTED
Affimed
AFMD
| $107K | 0.01% |
148,315
|
|
||
203
Editas Medicine
EDIT
$326M
| – | – |
-400,000
|
|
||
204
Immuneering
IMRX
$336M
| – | – |
-12,073
|
|
||
205
Relmada Therapeutics
RLMD
$69.7M
| – | – |
-200,825
|
|
||
|
ALMS
206
Alumis Inc
ALMS
$472M
| – | – |
-600,000
|
|
||
|
OMIC
207
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| – | – |
-372,000
|
|
||
|
MRNS
208
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| – | – |
-1,641,945
|
|